NCYT — Novacyt SA Share News
0.000.00%
- £28.73m
- £30.99m
- £20.03m
France's Novacyt H1 revenue rises on Southern Cross Diagnostics acquisition
Novacyt S.A. - 2026 Interim Results
Novacyt S.A. - Notice of Results
Novacyt S.A. - Launch of IVDR-Certified Yourgene® DPYD Assay
Novacyt S.A. - Master Collaboration Agreement with Illumina
France's Novacyt H1 revenue rises on SCD acquisition
Novacyt S.A. - Half-year trading update
Novacyt S.A. - AGM Voting
Press Digest: British Business - June 2
Novacyt S.A. - Operational Update
Novacyt S.A. - Notice of AGM
Novacyt S.A. - Directorate change
Brief: Novacyt Reports Group Headcount For 2025 At 224, Down 7% From Opening Headcount
Novacyt S.A. - Full Year 2025 results
Novacyt S.A. - Notice of Results and Investor Presentation
Novacyt S.A. - Director/PDMR Shareholding
Novacyt S.A. - Completion of Acquisition
Brief: Novacyt S.A. To Buy Southern Cross Diagnostics For AUD$8.5M
Novacyt S.A. - Acquisition of Southern Cross Diagnostics